SAVA
Cassava Sciences Inc.
Company Overview
| Mkt Cap | $110.14M | Price | $3.26 |
| Volume | 1.45M | Change | -0.61% |
| P/E Ratio | -4.5 | Open | $3.28 |
| Revenue | -- | Prev Close | $3.28 |
| Net Income | $-24.3M | 52W Range | $1.15 - $33.98 |
| Div Yield | N/A | Target | $2.00 |
| Overall | 42 | Value | 60 |
| Quality | 26 | Technical | 41 |
No chart data available
Stock Overview
Updated DailyCassava Sciences Inc. (SAVA) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.26 with a market capitalization of $110.14 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows SAVA with a volume of 1.45 million shares. The stock opened down 0.00% from yesterday's close of $3.28. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
SAVA demonstrates weak technical indicators based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for SAVA include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -38.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:55 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SAVA | $3.26 | -0.6% | 1.45M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |